SLP
Simulations Plus, Inc.
1 day chart
About SLP
Simulations Plus, Inc. is a developer of modeling and simulation software for drug discovery and development. The Company provides prediction of properties of molecules utilizing both artificial intelligence (AI) and machine-based technology. It also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. It offers approximately 13 software products for pharmaceutical research and development, such as GastroPlus, DDDPlus, MembranePlus, ADMET Predictor, MedChem Designer, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite and PKPlus. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and academic and regulatory agencies worldwide for use in the conduct of industry-based research. Its subsidiaries include Cognigen Corporation, DILIsym Services, Inc. and Lixoft.
Buy US stocks in Australia starting with SLP. Open an account and start investing today!
$815.80M
-
0.59%
81.84K
$41.65
$40.65
$41.10
$52.69
$32.58
SLP FAQs
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in SLP
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.